Comparison of efficacy and safety between febuxostat and allopurinol in early post‐renal transplant recipients with new onset of hyperuricemia

WHAT IS KNOWN AND OBJECTIVE: Febuxostat and allopurinol are xanthine oxidase inhibitors for urate‐lowering therapy. The efficacy and safety of febuxostat and allopurinol have been mostly reported in hyperuricemia patients with normal renal function. Here, we aimed to compare the effects of these two...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xiaoju, Li, Jingjie, Fu, Qian, Liu, Longshan, Gao, Xiang, Chen, Xiao, Chen, Pan, Wang, Changxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379739/
https://www.ncbi.nlm.nih.gov/pubmed/30582178
http://dx.doi.org/10.1111/jcpt.12794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379739/
https://www.ncbi.nlm.nih.gov/pubmed/30582178
http://dx.doi.org/10.1111/jcpt.12794

Ejemplares similares